Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).| Product Name | TRAFD1 [E7-E6] |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | FLN29 antibody FLN29 gene product antibody Protein FLN29 antibody TRAD1_HUMAN antibody TRAF type zinc finger domain containing 1 antibody TRAF type zinc finger domain containing protein 1 antibody TRAF-type zinc finger domain-containing protein 1 antibody TRAFD 1 antibody TRAFD1 antibody |
| Product description | Negative feedback regulator that controls excessive innate immune responses. Regulates both Toll-like receptor 4 (TLR4) and DDX58/RIG1-like helicases (RLH) pathways. May inhibit the LTR pathway by direct interaction with TRAF6 and attenuation of NF-kappa-B activation. May negatively regulate the RLH pathway downstream from MAVS and upstream of NF-kappa-B and IRF3. |
| Immunogen | Recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG1 |
| Host Species | Mouse |
| Tested Applications | WBICCFC |
| WB:1:250~1:1000 ICC:1:100~1:200 FC:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Concentration | 2mg/ml |
| Alternative Names | FLN29 antibody FLN29 gene product antibody Protein FLN29 antibody TRAD1_HUMAN antibody TRAF type zinc finger domain containing 1 antibody TRAF type zinc finger domain containing protein 1 antibody TRAF-type zinc finger domain-containing protein 1 antibody TRAFD 1 antibody TRAFD1 antibody |
|---|---|
| Molecular Weight(MW) | 65 kDa |
| SwissProt ID | O14545 |
|---|
Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).
Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).
Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).
Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).
Application
Fig5: Flow cytometric analysis of Hela cells with TRAFD1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; purple).| Positive Control | Human TRAFD1 recombinant protein, TRAFD1-hIgGFc transfected HEK293 cell lysate, HEK293, Raji, Jurkat cell lysate. HepG2. Hela |
|---|---|
| Application Notes | WB:1:250~1:1000 ICC:1:100~1:200 FC:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
